PTPRC and neoplasm: Consistent with UMAP clustering analysis, we found that anti-PD-L1 treatment did not affect gene expression in CD45+ tumor-infiltrating immune cells in TAb2 tumors globally shown by volcano plots (Fig. 7E, left).